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Abstract A total of 103 group B streptococci (GBS) includ-
ing 22 invasive, 21 non-invasive, and 60 colonizing isolates
were collected in a Malaysian hospital (June 2010–October
2011). Isolates were characterized by conventional and mo-
lecular serotyping and analyzed for scpB, lmb, hylB, cylE, bac,
bca and rib gene content. Antimicrobial susceptibility to
penicillins, macrolides, lincosamides, quinolones and tetracy-
clines was determined using disk diffusion and the MICs for
penicillin were determined by E-test.Molecular serotyping for
all eight serotypes (Ia, Ib, II–VII) was in full accordance with
conventional serotyping. Overall, taking CS and MS together,
serotype VI was the most common capsular type (22.3 %)
followed by VII (21.4 %), III (20.4 %), Ia (17.5 %), V (9.7%),
II (7.7 %) and IV (1 %). Susceptibility to beta-lactam antimi-
crobials was prevalent (100 %). Resistance rates for erythro-
mycin, clindamycin and tetracycline were 23.3 %, 17.5 % and
71.8 %, respectively. PCR-virulence gene screening showed
the presence of cylE, lmb, scpB and hylB in almost all the
isolates while rib, bca, and bac genes were found in 29.1 %,
14.6 % and 9.7 % of the isolates. Certain genes were signif-
icantly associated with specific serotypes, namely, rib with
serotypes Ia, II, III and VI; bca and bac with serotypes II and
III. Furthermore, serotype Ia was significantly more common
among patients with invasive infections (p<0.01) and sero-
type VI isolates were significantly more common among
carriers (p<0.05). In summary, serotype distribution correlates
with virulence gene content will be useful in epidemiological
studies and design of vaccines.
Introduction
Streptococcus agalactiae, the group B streptococcus (GBS), is
a gram-positive and encapsulated bacterium, which displays
beta-hemolytic activity on blood agar. It is part of the com-
mensal flora in the genital and lower gastrointestinal tracts in
10–40 % of healthy adults [1]. However, vaginal colonization
by GBS during pregnancy may be clinically significant be-
cause it is associated with neonatal meningitis and septicemia
[2]. During recent decades, GBS infection has increasingly
emerged in adults, particularly those with underlying illness
such as diabetes [3].
Penicillin is the first-line agent for prevention and treatment
of GBS infections [1, 4]; however, since 1994, GBS isolates
with reduced susceptibility to penicillin have been reported
periodically [5]. In case of penicillin allergy, clindamycin and
erythromycin are the most recommended alternatives. Conse-
quently, the increasing use of these drugs, consumed by
around 20 % of all GBS carriers, resulted in elevated rates of
clindamycin and erythromycin resistance worldwide [6, 7].
Capsular serotype contributes to disease severity and defines
vaccine development [8]. Ten GBS capsular types have been
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identified (Ia, Ib and II-IX) and vaccination against five sero-
types (Ia, Ib, II, III and V) is in development [7, 9]. Several
investigations revealed that strains harboring the CPS types Ia,
II, III, and V are the most significant causes of GBS invasive
disease in neonates and other patients [10, 11]. PCR can
identify serologically non-typable strains since these generally
still carry the required genes [12]. Therefore, molecular
serotyping techniques have an elevated discriminatory power
for epidemiological studies [13].
GBS has many virulence factors including surface proteins,
toxins and hydrolytic enzymes [14]. Surface proteins mostly
function as adhesins, which may also contribute to immune
evasion. These include C5a peptidase (ScpB), laminin-
binding protein (Lmb), the α and β-subunits of C protein
(Bca and Bac) and Rib protein. GBS secrete a variety of toxins
such as β-hemolysin/cytolysin (cylE), hyaluronidase (hylE)
and the CAMP factor (cfb) which facilitate entry of GBS into
host cells and promote its intra-cellular survival [15].
Epidemiological studies on GBS, assessment of their anti-
biotic susceptibility and conventional serotyping are sparse in
Malaysia. Molecular serotyping and virulence determinants of
Malaysian GBS are published for the first time in this study.
Materials and methods
Bacterial isolates
A total of 103 pure cultures of GBS were obtained from
outpatients and inpatients at the Universiti Kebangsaan Ma-
laysia Medical Centre (UKMMC), a 900-bed teaching and
referral hospital in Malaysia (June 2010–October 2011). Iso-
lates were grouped into three different types based on the
clinical outcome and site of isolation: invasive (n =22) for
isolates derived from normally sterile body site such as blood;
non-invasive isolates (n =21) for isolates derived from wound
and skin ulcers, tracheal and gastric aspirates; colonizing
isolates (n =60) derived from vaginal swabs and urine samples
from asymptomatic patients. Basically, pure GBS cultures
were obtained except for 10 (9.7 %) cases in which GBS
coexisted with other organisms (e.g. Staphylococcus aureus,
coagulase-negative staphylococci, Escherichia coli,
Pseudomonas aeruginosa, Klebsiella species or unspec-
ified gram positive and negative cocci). Identification
was carried out based on culture characteristics, Gram
staining, catalase testing and CAMP testing. The species
nature of the isolates was confirmed by slide agglutination
using Streptex (Murex Diagnostics, UK) and by conventional
PCR assays targeting the cfb gene (encoding the CAMP
factor). All strains were preserved in sterile nutrient broth with
15 % glycerol and on beads in cryo-vials (Pro-Lab, UK) at
−70 °C for long-term storage and on 5 % sheep blood agar
plates at 4 °C for short-term maintenance.
Serotyping
Capsular serotyping was performed by the latex agglutination
method using antisera specific for each capsular type (Ia, Ib,
II-VII) using Strep-B-Latex kits (Statens Serum Institute, SSI,
Sweden). Isolates that did not react with any of the antisera
were classified as serologically non-typeable (NT). Further
confirmation of capsular types was performed for all strains
using PCR. The conventional PCR assay as developed for
seven GBS capsular types (Ia-VII) and targeting the cps gene
cluster was used according to Borchardt et al. [16]. DNAwas
extracted using GeneAll Exgene Mini genomic extraction kits
(GeneAll, South Korea) following the manufacturer’s instruc-
tions. The GBS reference strains A909 (type Ia), H36B (type
Ib), 18RS21 (type II), M78 (type III), CNCTC 1/82 (type IV),
BAA-611 (type V), NT6 (type VI), 7271 SSI (type VII) were
kindly provided by Universiti Kebangsaan Malaysia Medical
Centre.
Antimicrobial susceptibility testing
Antibiotic susceptibility testing (AST) was performed by the
disc diffusion (Kirby-Bauer) method according to the guide-
lines described by CLSI in 2012 [17]. The panel of antibiotics
included penicillins (penicillin G and ampicillin), cephalospo-
rins (cefuroxime and ceftriaxone), a quinolone (levofloxacin),
a glycopeptide (vancomycin), a macrolide (erythromycin), a
lincosamide (clindamycin), a phenicole (chloramphenicol)
and tetracycline. TheMIC for penicillin was determined using
pneumoniae ATCC 49619 as quality control. The diameters
of the inhibition zones and MICs were interpreted based on
CLSI interpretation guidelines (2012) [17]. Erythromycin re-
sistant, clindamycin sensitive strains were further tested by the
double-disc diffusionmethod (D-zone test) with erythromycin
and clindamycin disks 12 mm apart. Strains with D-shaped
clindamycin zones (inducible clindamycin resistance) were
considered as “clindamycin resistant”.
Determination of virulence genes
All GBS isolates were screened for the presence of seven
virulence genes, namely, scpB, lmb, hylB, cylE, bac, bca and
rib encoding C5a peptidase, laminin binding protein,
hyaluronate lyase, β-hemolysin/cytolysin, β-C protein, α-C
protein and Rib protein by using PCR. The oligonucleotide
primers and PCR cycling conditions were as reported by
others [18–21]. The GBS reference strains, ATCC 13813
(cfb), ATCC BAA-611 (rib), NCTC 11078 (bca, and bac),
ATCC 12403 (cylE), ATCC 12386 (lmb and scpB) and Strep-
tococcus agalactiae, strain 4755 (hylB), were included as
positive controls.
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the Etest® strip (bioMérieux, Marcy l’Etoile, France). Each
batch of tests was run concurrently with Streptococcus
Statistical analysis
The SPSS statistical analysis package (version 21.0 for Win-
dows) was used to analyze the significance of the results. Chi-
square tests of independence were performed to assess possi-
ble associations between the variables. The significance level
was set at p <0.05. If the chi-square test of independence was
statistically significant, then post-hoc comparison tests were
conducted to determine the variable that produced the statis-
tically most significant difference. The obtained standard re-
sidual (std.res) from post-hoc analysis was considered signif-
icant when std.res >1.96, >2.58 and >3.33 were at 0.05, 0.01
and 0.001 level of significance.
Results
Clinical data of all patients are summarized in Table 1. Among
the 103 GBS isolates, 11 (10.7 %) were from neonates, all of
whom presented with early-onset disease (<7 days old) and
more than half of the neonates (64 %) were known to have
GBS bacteremia. Ninety-two isolates (89.3%) were recovered
from adults (age range 20–87). In non-pregnant adults
(n =43), GBS isolates were often isolated from blood
(37.3 %), vagina (35 %), wound and abscess specimens
(26%). Urine sample yielded only one isolate (1.7%). Among
pregnant women, most of the GBS isolates were recovered
from vaginal specimens (90 %). Blood, urine and placenta
swabs yielded a few additional isolates (10 %).
Comparison of conventional serotyping (CS) with molecular
serotyping (MS)
CS was able to identify the capsular serotypes of 80.6 %
(83/103) of the GBS isolates studied and 20 (19.4 %) isolates
remained non-typable. All GBS isolates were also tested by
MS in order to confirm the accuracy of CS. MS was in
accordance with CS for the CS-typeable isolates. MSwas able
to detect capsular serotype genes in all 20 (19.4 %) sero-
logically non-typable isolates. Six isolates showed sero-
type III while the remaining 14 isolates were of serotype
VII. Overall, taking CS and MS together, serotype VI was
the most common capsular type (n =23, 22.3 %) followed
by VII (n =22, 21.4 %), III (n =21, 20.4 %), Ia (n =18,
17.5 %), V (n =10, 9.7 %), II (n =8, 7.7 %) and IV (n =1,
1 %). No serotype Ib isolates were found in the present study.
Antimicrobial susceptibility profiles
All GBS strains were susceptible to penicillin G, ampicilin,
cefuroxime, ceftriaxone, levofloxacin, vancomycin and chlor-
amphenicol. A hundred percent susceptibility to penicillin
was also confirmed by E-test where the MIC ranged from
0.023 to 0.064 μg/ml. The AST results showed that the
majority of isolates (n =74, 71.8 %) were resistant to tetracy-
cline. Twenty-four isolates (23.3 %) were resistant to erythro-
mycin and 18 (17.5 %) to clindamycin. Only one case of the
18 resistant isolates showed inducible clindamycin resistance.
PCR amplification of the virulence genes
All isolates were positive for the cfb gene, which helped to
confirm the species identity of GBS. Genes encoding the β-
hemolysin/cytolysin (βH/C), laminin binding protein, C5a
peptidase, and hyaluronate lyase (cylE, lmb, scpB and hylB)
were present in 97.1%, 97.1%, 96.1% and 94.2% of isolates,
respectively, making them the predominant virulence genes.
The rib, bca, and bac genes were found in 29.1 %, 14.6 % and
9.7 % of the isolates, respectively.
Association of genotypic traits with molecular serotyping
The distribution of three genotypic traits (bac, bca, rib) and
various serotypes are presented in Table 2. As cylE, lmb, scpB,
hylB were detected in almost all GBS isolates (97.1 %,
97.1 %, 96.1 %, 94.2 %, respectively), these were excluded
from the analysis. Serotype IV was detected only once and
was also excluded. The rib gene is significantly associated
with serotype Ia, VI (p<0.05), II and III (p<0.01). The bca
gene was more common among serotype II (p<0.001) and III
(p<0.01) strains. A significant association was also found
between the bac gene and serotype II (p<0.001) and III
(p<0.05) (Table 2).
Table 1 Distribution of 103 GBS isolates among patient groups









Neonate 11 (10.7) 7 4 0 11
Pregnant adults 49 (47.6) 0 3 46 49
Non-pregnant adults 43 (41.7) 15 14 14 43
Total 103 (100) 22 21 60 103
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Although all serotypes were observed among the three
populations studied, serotype Ia was significantly more com-
mon among patients with invasive infections (p<0.01) and
serotype VI isolates were significantly more common among
carriers (p<0.05) (Table 3).
No statistically significant associations were found be-
tween the virulence genes and the isolate status or age of
patients in the present study (p >0.05).
Discussion
In Malaysia, data on detection of GBS virulence genes and
molecular serotyping are non-existent. In the present research,
GBS isolates were serotyped by both phenotypic and geno-
typic approaches and further characterized for their virulence
patterns and antibiotic susceptibility profiles.
Serotype distribution of GBS isolates has previously been
reported to vary geographically [9, 22]. In the present study,
MS results showed serotype VI (22.2 %) to be overrepresented
in the Malaysian population. In contrast, an older study found
lower numbers of serotype VI isolates among adults and
neonates [23]. Serotype VII is rarely reported worldwide [7,
24, 25]; however, we found a relatively high number of strains
with serotype VII (n =22, 21.3 %) among Malaysians. Only
eight GBS isolates from our study were CPS type II while a
cross-sectional study in South East Asia reported this type as
predominant among pregnant women [22]. Serotype Ia was
significantly more common among patients with invasive in-
fections (p<0.01) and serotype VI isolates were significantly
more common among carriers (p<0.05). All isolates were
typable by MS, while a considerable proportion (19.4 %) of
isolates could not be typed by CS, as also observed in previous
studies [9, 26, 27].
The overall beta-lactam susceptibility of Malaysian GBS
was confirmed here [1, 4, 22]. Neither penicillin-resistant nor
penicillin intermediate GBS strains were detected. Some in-
vestigations have identified GBS isolates with reduced sensi-
tivity [5, 28, 29]. Hence, penicillin could still be used as a first-
line drug for intra-partum prophylaxis and treatment of GBS
infections in Malaysia.
The rates of resistance to erythromycin and clindamycin
were lower than those in the studies from Japan, Europe and
the United States [30, 31], but can be considered high in
comparison to the studies from Asian countries [32, 33]. The
resistance documented for erythromycin and clindamycin
provides a warning that these drugs need to be prescribed with
care since also non-susceptible GBS were observed in the
United States and Japan [28, 34].
The frequency of virulence gene rib presence is similar to
other studies from Europe, the United States and Lebanon [15,
18, 35] and higher than those reported among pregnant wom-
en in Poland and Kuwait [14, 36]. The bca encodes α-C
surface protein (ACP) was observed in a lower frequency than
in previous reports, where its presence varied from 42 to 85 %
[15, 36, 37]. Another study has identified the bca gene in
100 % of strains; however, in this case only potentially clonal
type Ia strains were tested [38]. The bac gene was found at a
lower frequency (9.7%) as compared to other studies from the








Ia 10 (45.5)** 6 (28.6) 2 (3.4)
II 1 (4.5) 0 (0.0) 7 (11.8)
III 2 (9.1) 4 (19.0) 15 (25.0)
V 1 (4.5) 2 (9.5) 7 (11.8)
VI 3 (13.7) 3 (14.3) 17 (30.0)*
VII 5 (22.7) 6 (28.6) 11 (18.0)
*p<0.05, **p<0.01
Table 2 Association between capsular serotype and virulence genes in 103 isolates of group B streptococcus
Serotype rib+ p-value bca+ p-value bac+ p-value
Ia 1 (5.0 %) < 0.05 0 (0.0 %) > 0.05 0 (0.0 %) > 0.05
II 7 (87.5 %) < 0.01 7 (87.5 %) < 0.001 5 (62.5 %) < 0.001
III 12 (63.2) < 0.01 8 (42.1 %) < 0.001 5 (26.3 %) < 0.01
V 3 (37.5 %) > 0.05 0 (0.0 %) > 0.05 0 (0.0 %) > 0.05
VI 2 (7.7 %) < 0.05 0 (0.0 %) > 0.05 0 (0.0 %) > 0.05
VII 5 (23.8 %) > 0.05 0 (0.0 %) > 0.05 0 (0.0 %) > 0.05
Total 30 (29.4) 15 (14.7 %) 10 (9.8 %)
rib + , bca + and bac+ indicates presence of rib, bca and bac genes
std. res >1.96, p<0.05
std. res >2.58, p<0.01
std. res >3.33, p<0.001
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United States, Europe and New Zealand [7, 18, 39]. A recent
study among pregnant women in Kuwait detected bac in only
3.2 % of isolates [37].
Certain virulence genes were significantly more prevalent
in given CPS types. For instance, rib was associated
significantly with serotypes Ia, II, III and VI. Previous
data from South East Asian countries and Europe con-
firmed the association between rib gene and serotype Ia,
II and III [39–42]. Moreover, our results indicated a
significant association between serotypes II and III with
bca and bac, while other studies demonstrated associa-
tion between bca and bac with serotype Ib and II [35,
39, 41]. According to Duarte et al. (2005) around 30–
55 % of serotype Ia GBS isolates in humans harbored
the bca gene [20]. In another study reported by Dore
et al. around 50 % of serotype III isolates harbored the
bca or bac or both [42]. This difference may be caused
by geographical differences in prevalence or may indi-
cate the appearance of silent bca and bac genes in these
serotypes.
The present study could not demonstrate any correlation
between the virulence genes and clinical status of the patients
from whom the isolates were obtained (p >0.05); however, as
pointed out by Maning et al. invasive isolates showed a
tendency to have rib and bac [18]. No significant associations
were found between the occurrence of virulence genes and the
age of patients in the present study (p >0.05). However, based
on data presented by Ho et al. the majority of bca genes
(85.4 %) in GBS isolates were observed in strains from adults,
whereas 59.2% of rib gene was harbored among isolates from
neonates [40]. Given the lack of correlation we describe
above, our data do not confirm the virulence potential of the
genes detected.
In conclusion, our GBS collection contained a high
number of strains with serotypes VI and VII, in contrast
to findings in other countries [7, 24, 43]. Such differ-
ences in the relative regional incidence of serotypes
could compromise the efficacy of vaccine. Additionally,
the present study clearly shows the equivalence of MS and CS
and indicates the broader coverage ofMS. Data presented here
confirms previous findings on the relationship between differ-
ent virulence genes and serotypes but fails to confirm the
virulence contribution of the panel of potential virulence
genes we screened for.
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